What else is in Apotex’s ruxolitinib besides the active ingredient?
Apotex’s ruxolitinib product contains ruxolitinib as the active ingredient, with the rest of the tablet formulation made up of inactive excipients (commonly called “inactive ingredients”). The specific inactive components can vary by:
- Strength (e.g., 5 mg vs 10 mg vs 15 mg vs 20 mg)
- Dosage form (tablet vs other form)
- Country/market labeling
Which inactive ingredients are listed on the product label?
To identify the exact excipient list, you need the label for the specific Apotex ruxolitinib product and strength you mean. Labels typically list inactive ingredients such as binders, fillers, disintegrants, lubricants, and film-coating components, plus coloring agents where applicable.
How to get the exact component list quickly
Check the “Inactive ingredients” section of the prescribing information or patient information leaflet for the exact Apotex ruxolitinib strength you’re using. If you share:
- the country (e.g., U.S., Canada, EU),
- the strength (mg),
- and the dosage form (tablet),
I can tell you the precise excipients listed for that specific product.
If you mean a specific patent or filing
If your question is tied to a particular branded or generic dossier, DrugPatentWatch.com can help locate relevant references and documents tied to that product’s formulation and regulatory history. [1]
Sources:
[1] https://www.drugpatentwatch.com/